Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.63
Delayed Data
As of Aug 25
 -0.09 / -1.91%
Today’s Change
2.80
Today|||52-Week Range
7.80
-8.32%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Holmes Scott A
Chief Financial Officer
Sale7/29/20164,935$7.36$36.3K-37.09%
Neylan John F /keryx/
Chief Medical Officer
Sale4/25/20164,766$5.21$24.8K-11.98%
Madison Gregory P
President & Chief Executive Officer
Sale1/06/20164,261$4.83$20.6K+4.75%
Holmes Scott A
Chief Financial Officer
Buy11/03/20153,672$5.30$19.5K-14.26%
Adams Brian R
Vice President & General Counsel
Sale1/05/20163,003$4.83$14.5K-3.54%
Madison Gregory P
President & Chief Executive Officer
Sale5/09/20161,873$5.42$10.2K-15.36%
Neylan John F /keryx/
Chief Medical Officer
Sale7/25/20161,217$7.43$9.0K-37.60%
Madison Gregory P
President & Chief Executive Officer
Sale11/09/20151,638$5.18$8.5K-15.36%
Adams Brian R
Vice President & General Counsel
Sale7/15/20161,083$7.01$7.6K-34.70%
Holmes Scott A
Chief Financial Officer
Buy11/04/20151,328$5.40$7.2K-14.10%
Page of 3